fludarabine has been researched along with Hemoglobinuria, Paroxysmal in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrett, J; Childs, RW; Cook, L; Donohue, T; Geller, N; Khuu, H; Kurlander, R; Leitman, S; Pantin, J; Ramos, C; Shah, AA; Stroncek, D; Tian, X; Young, NS | 1 |
| Barrett, J; Childs, RW; Cho, E; Cook, L; Donohue, T; Geller, N; Khuu, H; Pantin, J; Ramos, C; Scheinberg, P; Stroncek, D; Tian, X; Vasu, S; Young, NS | 1 |
| Chen, J; Ding, L; Li, B; Li, Q; Luo, C; Wang, J | 1 |
| Chang, W; Chen, F; Fu, C; Jin, Z; Ma, X; Miao, M; Qiu, H; Ruan, C; Sun, A; Tang, X; Wu, D; Xue, S | 1 |
| Chi, HS; Choi, SJ; Kim, S; Kim, WK; Lee, JH; Lee, JL; Lee, JS; Lee, KH; Lee, YS; Park, CJ; Seol, M | 1 |
| Nakao, S | 1 |
| Barrett, AJ; Childs, RW; Dorrance, C; Espinoza-Delgado, I; Geller, N; Igarashi, T; Lundqvist, A; McCoy, JP; Srinivasan, R; Takahashi, Y; Young, NS | 1 |
| Balère-Appert, ML; Boiron, JM; Bordigoni, P; Chir, Z; Galambrun, C; Kanold, J; Maillard, N; Marie-Cardine, A; Maury, S; Milpied, N; Socié, G; Yakouben, K | 1 |
| Ambinder, RF; Bolaños-Meade, J; Borrello, I; Brodsky, RA; Chen, AR; Flowers, M; Fuchs, EJ; Gooley, TA; Harrington, E; Huff, CA; Jones, RJ; Kaup, M; Leffell, MS; Luznik, L; Matsui, W; O'Donnell, PV; Piantadosi, S; Powell, JD; Sandmaier, BM; Storb, RF; Symons, HJ; Warnock, S; Zahurak, M | 1 |
1 review(s) available for fludarabine and Hemoglobinuria, Paroxysmal
| Article | Year |
|---|---|
[Non-myeloablative stem cell transplantation for non-malignant hematologic disorders].
Topics: Anemia, Aplastic; Animals; Antilymphocyte Serum; Cyclophosphamide; Hematopoietic Stem Cell Transplantation; Hemochromatosis; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2003 |
3 trial(s) available for fludarabine and Hemoglobinuria, Paroxysmal
| Article | Year |
|---|---|
Rapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromes.
Topics: Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Agents; Bone Marrow Diseases; Bone Marrow Failure Disorders; Child; Chronic Disease; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Risk Factors; Salvage Therapy; T-Lymphocytes; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Young Adult | 2013 |
Allogeneic hematopoietic cell transplantation for paroxysmal nocturnal hemoglobinuria.
Topics: Adolescent; Adult; Antilymphocyte Serum; Busulfan; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Histocompatibility; Humans; Male; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2003 |
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.
Topics: Adult; Aged; Blood Component Transfusion; Bone Marrow Transplantation; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Female; Filgrastim; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hemoglobinuria, Paroxysmal; Histocompatibility; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Postoperative Care; Postoperative Complications; Recombinant Proteins; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2008 |
5 other study(ies) available for fludarabine and Hemoglobinuria, Paroxysmal
| Article | Year |
|---|---|
Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria.
Topics: Adult; Female; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Humans; Male; Survival Analysis; Transplantation Conditioning; Treatment Outcome; Vidarabine; Young Adult | 2014 |
[Molecular diagnosis and hematopoietic stem cell transplantation in 17 children with inherited bone marrow failure syndrome].
Topics: Anemia, Aplastic; Anemia, Diamond-Blackfan; Bone Marrow Diseases; Bone Marrow Failure Disorders; Child; Dyskeratosis Congenita; Fanconi Anemia; Fetal Blood; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Humans; Retrospective Studies; Siblings; Survival Rate; Transplantation Conditioning; Unrelated Donors; Vidarabine | 2015 |
[Outcomes of allogeneic hematopoietic stem cell transplantation for 18 patients with paroxysmal nocturnal haemoglobinuria].
Topics: Anemia, Aplastic; Antilymphocyte Serum; Busulfan; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Humans; Methotrexate; Mycophenolic Acid; Retrospective Studies; Siblings; Tacrolimus; Transplantation Conditioning; Treatment Outcome; Unrelated Donors; Vidarabine | 2015 |
Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Bone Marrow Diseases; Child; Female; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Humans; Male; Middle Aged; Survival Analysis; Transplantation Conditioning; Treatment Outcome; Vidarabine | 2006 |
Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Cause of Death; Chi-Square Distribution; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Hepatitis; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Kaplan-Meier Estimate; Living Donors; Lymphocyte Depletion; Male; Middle Aged; Proportional Hazards Models; Reoperation; Retrospective Studies; Statistics, Nonparametric; Survival Analysis; Survival Rate; T-Lymphocytes; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2007 |